本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Oncolytics Biotech Inc

0.8127
+0.06729.01%
盤後0.82110.0084+1.03%19:50 EDT
成交量:140.04萬
成交額:112.49萬
市值:1.04億
市盈率:-2.53
高:0.8501
開:0.7621
低:0.7556
收:0.7455
52周最高:1.51
52周最低:0.7301
股本:1.28億
流通股本:1.23億
量比:0.95
換手率:1.14%
股息:- -
股息率:- -
每股收益(TTM):-0.3215
每股收益(LYR):-0.3000
淨資產收益率:-10187.64%
總資產收益率:-211.24%
市淨率:-16.80
市盈率(LYR):-2.71

資料載入中...

2021/03/05

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/24

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/06

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]